IT Solution for EU-compliant Drug Protection
- Arvato Systems implements National Verification System for Austria, implementing EU anti-counterfeiting directives
- AMVO (Austrian Medicines Verification Organisation) counts on Arvato Systems for implementation of the major project
(Arvato Systems) Gütersloh – Arvato Systems responsible for implementation and operation of Austrian national IT platform for the verification of medication. This decision represents an important milestone in the implementation of the EU Falsified Medicines Directive for AMVO, an organization which includes Pharmig (the Austrian pharmaceutical industry group), the Austrian Generics association, PHAGO (the association of Austrian medical wholesalers), as well as the Austrian Chamber of Pharmacies. The goal is to be part of the EU-wide fight against counterfeit medications entering legal distribution chains.
Directive 2011/62/EU is the start of the EU initiative against counterfeit medications. From February 9, 2019 prescription drugs may only be sold in Europe if each package has a unique serial number.
The serial number – a printed data matrix code – is one of the keystones of the security concept. As well as the data matrix code, packages must be tamper-proofed. The biggest challenge is in the verification of each individual identification code. As well as the serial number, the data matrix code contains the product code, information about the product batch and the expiry date. Each package of medication is therefore unique.
The national verification system enables end-to-end serialization for drug packaging, from pharmaceutical manufacture through to in-store pharmacy verification.
“All pharmaceutical companies in Austria; all pharmaceutical wholesalers, all Austrian pharmacies as well as all hospital pharmacies and doctors with an in-house pharmacy are required to connect to the national verification system – a major IT project”, comments AMVO Chairman Dr. Jan Oliver Huber on the practical implications of implementing the regulations at the EU level.
“We are delighted to see that Austria is ready to rely on the skill-sets and IT competencies of Arvato Systems”, says Peter Koop, Vice President for Healthcare at Arvato Systems. “For AMVO, implementation of these requirements means an investment of millions of euros. With our EU-wide experience we will be a solid and reliable IT partner for Austria.”
AMVO, the Austrian Medicines Verification Organisation, is responsible for managing the Austrian medication verification system. The organization was founded by Pharmig, the Austria Generics Association, PHAGO and the Austrian Chamber of Pharmacies. The AMVO members undertake to work together on investigating and processing any events where counterfeiting is suspected. Competent authorities are involved via the supervision and control advisory committee, and so can fulfil their monitoring tasks.
About Arvato Systems
Global IT specialist Arvato Systems supports major companies through digital transformation. More than 3,000 staff in over 25 locations epitomize in-depth technology expertise, industry knowledge and focus on customer requirements. Working as a team, we develop innovative IT solutions, transition our clients into the Cloud, integrate digital processes and take on IT systems operation and support.
In Healthcare, Arvato Systems provides its own serialization solutions covering the entire end-to-end process chain. These solutions support both individual producers and national verification systems. Arvato Systems was chosen as an official service provider by the European Medicines Verification Organization (EMVO). We rely on a dedicated team of serialization experts that has already carried out numerous international projects.
As a part of the Bertelsmann-owned Arvato network, we have the unique capability to work across the entire value chain. Our business relationships are personal; we work with our clients as partners, so that together we can achieve long-term success. arvato-systems.com